2023年欧洲心脏病大会(演讲PPT):慢性心肾疾病的新共同框架.pdfVIP

  • 10
  • 0
  • 约2.13万字
  • 约 12页
  • 2023-09-21 发布于湖北
  • 举报

2023年欧洲心脏病大会(演讲PPT):慢性心肾疾病的新共同框架.pdf

The emerging common framework of a chronic heart and kidney disorder Faiez Zannad, MD, PhD Professor of Therapeutics and Cardiology, University of Lorraine Medicine, France Finerenone is indicated for the treatment of chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults. For prescribing information please refer to the SmPC of the product applicable in your country. Date of preparation: August 2023 Approval code: MA-M_FIN-NL-0044-1 Disclosures Professor Zannad has received the following: • Steering and DSMB Committee

文档评论(0)

1亿VIP精品文档

相关文档